net dbt
thought sale issu japan
sale pressur expect japan
expect sale pressur japan follow investig practic
may disadvantag custom accord sourc japan undergo
rigor investig process temporarili halt sale
product continu distribut product given issu japan
mention see materi declin cancer insur sale recent
manag expect sale japan year-over-year
follow strong project sale normal modestli higher
predic quickli investig japan resolv new
process implement view earn impact modest
sale issu blemish market percept growth prospect
thorough review on-going jp still expect invest
undergo thorough review sale japan specif
review tie laps reissu cancer insur polici custom
custom would trade old polici newer polici updat benefit
price laps reissu laps reissu compliant practic
chanc custom disadvantag activ spike
recent given introduct refresh cancer product aflac
manag believ review impact japan post invest
stock share next twelv month howev view rais
question sinc japan inadvert benefit abl purchas
stock discount price
lower po sale pressur premium val warrant
lower price object given uncertainti around sale
japan po base ep estim premium
peer given defens busi mix taken lightli
stock meaning outperform peer last five year despit growth
challeng market reward progress higher earn multipl given
limit exposur key theme impact peer includ low long-term
interest rate pressur fee flow asset manag retir
challeng legaci liabil regulatori uncertainti reiter neutral rate
next two quarter could challeng given elev expens well
potenti modest earn impact sale issu guidanc view
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
aflac inc life health insur
compani market supplement insur
individu japan compani
disabl insur product market
mainli worksit payroll-deduct basi
also channel
deriv earn japan
 aflac focu supplement health
product make earn balanc sheet less
sensit chang interest rate peer
capit manag strong last
sever year expect trend continu
pressur
japan import distribut partner
japan hold import channel help compani penetr
greater portion japanes popul unlik unit state japanes
consum frequent purchas insur post offic began
distribut cancer insur product postal servic
japan hold enter agreement expand distribut relationship
introduc uniqu cancer product sell across kampo japan insur
directli manag sale offic well postal offic across japan
japan sale repres aflac japan third sector sale
given success launch refresh cancer product greater
penetr postal channel remaind sale gener
tradit channel includ individu corpor agenc well
allianc bank across japan
improp sale discov post offic
accord variou sourc japan found sever polici sold
improperli consum recent japan undergo rigor investig
process temporarili halt sale product continu
distribut product given issu japan mention see
materi declin cancer insur sale post offic recent
typic daili volum manag expect sale japan
year-over-year follow strong expect total japan third sector first
sector protect sale mid-teen entir year project sale
normal modestli higher predic quickli
investig japan resolv new process implement
current believ earn impact limit
view earn impact modest sale issu
blemish market percept growth prospect japan earn
premium growth expect materi impact sale
recov could impact premium growth beyond view
believ possibl could incur modestli higher expens remedi
issu japan believ outlook could reflect potenti modest impact
sale issu chang oper ep estim time
undergo thorough review
undergo thorough review sale japan specif
review tie laps reissu cancer insur polici custom
custom would trade old polici newer polici updat benefit
price laps reissu introduct revis cancer insur product
led spike laps reissu activ japan laps
reissu compliant practic chanc custom
disadvantag activ certain time custom would hold onto old
polici avoid coverag gap new polici total
polici last year subject laps reissu
japan still expect acquir share
end japan enter basic agreement japan
would purchas share worth billion purpos
strengthen allianc distribut product rather japan
mere acquir control japan begun purchas stock may
expect acquir stake twelv month period reach
report sec make announc increment
compani could increas vote share stake maximum
multi-year period manag believ review impact japan
invest rais question view sinc japan inadvert
benefit sinc abl purchas stock discount price stock
high mid-juli view invest agreement favor
align japan success
defens qualiti busi mix taken lightli
stock meaning outperform life insur compani last
five year despit growth challeng market reward share
progress higher earn multipl given lack exposur key theme
impact sever peer includ low long-term interest rate pressur
fee flow asset manag retir exposur challeng legaci
liabil long-term care insur regulatori uncertainti depart
labor fiduciari rule sifi design believ defens
qualiti taken lightli sale pressur creat near-term
uncertainti qualiti busi mix superior peer
price object base multipl oper ep
estim target multipl post crisi averag rang given
defens busi model robust capit manag
downsid risk achiev po deterior margin lower-than-
expect sale premium growth lower-than-project capit manag
upsid risk po stronger-than-expect margin higher-than-project sale
premium growth higher-than-anticip capit manag stronger
ian ryav cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
